Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LeanDose vs Vaylen

LeanDose
Graded #184

Lower grade

vs+10.900000000000006
Vaylen
Graded #44

Higher grade

The verdict

Vaylen takes it — 77.7/100 to 66.8/100.

Vaylen grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Vaylen is a pure GLP-1 specialist offering compounded semaglutide ($179/mo), compounded tirzepatide ($239/mo), compounded oral GLP-1 ($259/mo), and brand-name Ozempic, Zepbound, and Wegovy.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueVaylen +1
65
66
Dose & formulationVaylen +24
64
88
Clinical oversightVaylen +5
79
84
Labs & monitoringVaylen +23
54
77
FulfillmentVaylen +11
79
90
Contract termsEven
55
55
LeanDose · left barVaylen · right bar

The numbers

MetricLeanDoseVaylen
WeighScore66.8/10077.7/100
GradeCC+
Scorecard rank#184#44
Semaglutide$159/mo (first-month rate, compounded)$179/mo (compounded)
Tirzepatide$279/mo (first-month rate, compounded)$239/mo (compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
LeanDose

Graded #184 · C

Strengths

  • Transparent all-inclusive first-month pricing (compounded semaglutide from $159, tirzepatide from $279)
  • Verifiable LegitScript certification (seal ID 49840868) and an FDA-registered compounding pharmacy
  • Doctor-prescribed and supervised, with personalized care plans and multi-state clinical support
  • Convenient at-home delivery; compounded semaglutide and tirzepatide options
  • Honest, modest social proof — 119 five-star patient reviews

Where it loses points

  • Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Headline rates are first-month pricing; your ongoing monthly cost may be higher
  • Available in multiple states but the full list is not published on the homepage
  • The compounding pharmacy is FDA-registered but not named
Vaylen

Graded #44 · C+

Strengths

  • Pure GLP-1 specialist — not a multi-category telehealth platform
  • All 50 states coverage with licensed clinicians
  • Both compounded and brand-name options (Ozempic, Wegovy, Zepbound)
  • Oral GLP-1 option (compounded dissolvable tablets) for needle-averse patients
  • LegitScript certified

Where it loses points

  • Compounded semaglutide at $179/mo is mid-range (not the cheapest)
  • Brand-name options at near-retail pricing ($997-$1,086/mo)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard